norfenefrine has been researched along with Diabetes Mellitus, Type 2 in 1 studies
norfenefrine: RN given refers to cpd without isomeric designation; structure
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schumann, U | 1 |
| Jenkinson, CP | 1 |
| Alt, A | 1 |
| Zügel, M | 1 |
| Steinacker, JM | 1 |
| Flechtner-Mors, M | 1 |
1 other study available for norfenefrine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Sympathetic nervous system activity and anti-lipolytic response to iv-glucose load in subcutaneous adipose tissue of obese and obese type 2 diabetic subjects.
Topics: Adrenergic Agonists; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycerol; Hum | 2017 |